Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Complex Generics: Gottlieb Eyes FDA Policy Changes To Speed Approvals

Apr 06 2017

• By Sue Sutter

Syringes stuck in a dartboard

Related Content

Complex ANDAs To Be Allowed Pre-Submission Product Meetings

Oct 24 2016

Mylan’s Generic Advair Delay Gives Leverage To Rivals

Mar 30 2017

Gottlieb Nomination As US FDA Chief Could Signal Changes To Generic Approval Process

Mar 13 2017

Carrots and Stick: Biopharma At The White House

Feb 01 2017

FDA’s Naloxone Product Approval Standards May See Changes

Oct 04 2016

Amphastar's Naloxone Nasal Spray Delayed; User Human Factors Study Among FDA Concerns

Feb 22 2017

EpiPen Outrage In Congress Puts Spotlight On FDA Generic Review

Aug 30 2016

Related Companies

Viatris Inc.

GSK plc

Endo, Inc.

Vyera Pharmaceuticals, LLC

Additional Topics

United States Generic Drugs FDA Regulation BioPharmaceutical

More from Generics

More from Biosimilars & Generics

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window